The mechanism of skeletal muscle contraction is a process that relies on calcium signaling. However, the physiological role ...

In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...

Researchers used AlphaFold3, the latest AI-based protein modeling system, to predict the structures of all 25 known human ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Glucagon-like peptide 1 receptor agonists were ...

The FDA has approved paltusotine, a selectively targeted somatostatin receptor type 2 nonpeptide agonist, for first-line treatment of certain patients with acromegaly, Crinetics Pharmaceuticals ...

Breaking a longstanding impasse in our understanding of olfaction, scientists at UC San Francisco have created the first molecular-level, 3D picture of how an odor molecule activates a human odorant ...

Eli Lilly (LLY) announced that the U.S. Food and Drug Administration has approved Inluriyo, an oral estrogen receptor antagonist, for the ...